Results 1 to 10 of about 9,652,955 (180)

Estimated cost of comprehensive syringe service program in the United States. [PDF]

PLoS ONE, 2019
ObjectiveTo estimate the cost of establishing and operating a comprehensive syringe service program (SSP) free to clients in the United States.MethodsWe identified the major cost components of a comprehensive SSP: (one-time start-up cost, and annual ...
Eyasu H Teshale, Alice Asher, Maria V Aslam, Ryan Augustine, Eliana Duncan, Alyson Rose-Wood, John Ward, Jonathan Mermin, Kwame Owusu-Edusei, Patricia M Dietz   +9 more
doaj   +5 more sources

Injections and infections: understanding syringe service program utilization in a rural state [PDF]

Harm Reduction Journal, 2021
Background Increasing rates of injection drug use (IDU) associated-infections suggest significant syringe service program (SSP) underutilization. Our study objective was to assess practices of safe injection techniques and to determine predictors of SSP ...
Kinna Thakarar, Nitysari Sankar, Kimberly Murray, Frances L. Lucas, Debra Burris, Robert P. Smith   +5 more
doaj   +6 more sources

Impact of lab-based drug checking services on syringe service program engagement in Maryland, USA [PDF]

Harm Reduction Journal
Purpose: The introduction of synthetic substances into the unregulated drug supply has driven a surge in overdose deaths, posing significant public health challenges in timely substance identification, engagement with people who use drugs (PWUD), and ...
Caitlin M. Berry, David Newton, Margaret Rybak, Gregory Malik Burnett, Marcela Najarro, Edward Sisco, Jasmine Lopes, Dennis Leber   +7 more
doaj   +4 more sources

Differential risks of syringe service program participants in Central Ohio: a latent class analysis [PDF]

Harm Reduction Journal, 2023
Background Significant heterogeneity exists among people who use drugs (PWUD). We identify distinct profiles of syringe service program (SSP) clients to (a) evaluate differential risk factors across subgroups and (b) inform harm reduction programming ...
Kyle J. Moon, Ian Bryant, Anne Trinh, Kathryn A. Hasenstab, Brittany Carter, Rick Barclay, Saira Nawaz   +6 more
doaj   +2 more sources

Willingness to use a mobile syringe service program among people who inject drugs in rural Appalachia [PDF]

Harm Reduction Journal
Background Rural people who use drugs face a litany of structural and psychosocial barriers to SSP utilization (e.g., unreliable transportation, stigma).
Alex Elswick, Amanda Fallin-Bennett, Tasfia Jahangir, Susan Westneat, April M. Young   +4 more
doaj   +2 more sources

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial [PDF]

Drug and Alcohol Dependence Reports, 2022
Background: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by understanding the program costs.
Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, Chunki Fong, Pedro Mateu-Gelabert, Kristen M Marks, Yesenia Aponte-Melendez, Bruce R Schackman   +7 more
doaj   +2 more sources

Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis [PDF]

Harm Reduction Journal, 2023
Background Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe service program (SSP) use.
April M. Ballard, Dylan Falk, Harris Greenwood, Paige Gugerty, Judith Feinberg, Peter D. Friedmann, Vivian F. Go, Wiley D. Jenkins, P. Todd Korthuis, William C. Miller, Mai T. Pho, David W. Seal, Gordon S. Smith, Thomas J. Stopka, Ryan P. Westergaard, William A. Zule, April M. Young, Hannah L. F. Cooper   +17 more
doaj   +2 more sources

Syringe service program leader and participant perspectives on reasons for opioid-stimulant co-use in the United States [PDF]

Drug and Alcohol Dependence Reports
Background: Opioids and stimulants are increasingly used together in North America. Using syringe service program (SSP) leaders’ and participants’ perspectives, we sought to identify reasons for intentional and unintentional co-use.
Barbara Andraka-Christou, Shana Harris, Whitney D. Margaritis, M.H. Clark, Fatema Z. Ahmed, Suhas Shewale   +5 more
doaj   +2 more sources

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial [PDF]

BMC Public Health, 2021
Background A key strategy for mitigating the current opioid epidemic is expanded access to medications for treating opioid use disorder (MOUD). However, interventions developed to expand MOUD access have limited ability to engage opioid users at higher ...
Dennis P. Watson, James A. Swartz, Lisa Robison-Taylor, Mary Ellen Mackesy-Amiti, Kim Erwin, Nicole Gastala, Antonio D. Jimenez, Monte D. Staton, Sarah Messmer   +8 more
doaj   +2 more sources

Predictors of COVID-19 vaccine uptake and preferences for service delivery among people who inject drugs accessing a syringe service program [PDF]

Harm Reduction Journal
Introduction Despite being disproportionately affected by the COVID-19 pandemic, people who inject drugs (PWID) have markedly lower and more variable rates of COVID-19 vaccine uptake—ranging from 10% to 81%—compared to 79% of all US adults.
Marina Plesons, Ethan Steinberg, Sabrina Soto Sugar, Monica Faraldo, Hansel E. Tookes, Tyler S. Bartholomew   +5 more
doaj   +2 more sources